Browsing by Author Brunetto, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue DateViews
 
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
Journal:Journal of Hepatology
Agarwal, KBrunetto, MSeto, WKWLim, YSFung, SMarcellin, PAhn, SHIzumi, NChuang, WLBae, HSharma, MJanssen, HPan, CCelen, MKFurusyo, NShalimar, DYoon, KTTrinh, HChan, HL
2018
10
 
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
Journal:PLoS One
Pan, CQChang, TTBae, SHBrunetto, MSeto, WKCoffin, CSTan, SKMo, SFlaherty, JFGaggar, ANguyen, MHCelen, MKThompson, AGane, EJBulterys, M
2021
 
Safety and efficacy at 1 year after switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in chronic HBV patients with risk factors for TDF use
Proceeding/Conference:Journal of Hepatology
Gane, ESeto, WKWJanssen, HCarantu, FAKim, HJAbdurakhmanov, DNishiguchi, SAndrzej, HBae, HMo, SSuri, VGaggar, AFlaherty, JFKao, JHBrunetto, MFerret, MB
2018
88
 
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Journal:The Lancet Gastroenterology & Hepatology
Buti, MGane, ESeto, WKWChan, HLChuang, WLStepanova, THui, AJLim, YSMehta, RJanssen, HAcharya, SKFlaherty, JMassetto, BCathcart, ALKim, KGaggar, ASubramanian, GMMcHutchison, JPan, CBrunetto, MIzumi, NMarcellin, P
2016
20
Showing results 1 to 4 of 4